Oppenheimer & Co Inc

Institutional investor · Portfolio as of Q3 2022

Q3 2022 biggest moves
  • TSLATSLA

    Tesla

    3× the shares

    now 0.7% of portfolio

  • MSFTMSFT

    Microsoft

    Cut 3%

    now 4.0% of portfolio

  • METAMETA

    Meta Platforms

    Cut 22%

    now 0.4% of portfolio

  • ALLYALLY

    Ally Financial

    Cut 92%

    now 0.0% of portfolio

1,423 changes in all

Top Holdings1,360 positions

Checking export access…
Activity:
AAPL

Apple Inc.

1.3M$176.6M4.1%$72.76+86.15%
12 qtrssince 2019-Q4
Decreased
0
MSFT

Microsoft Corporation

728,897$169.8M4.0%$158.90+41.57%
12 qtrssince 2019-Q4
Decreased
0
AMZN

Amazon.com, Inc.

637,489$72M1.7%$105.17+7.45%
12 qtrssince 2019-Q4
Decreased
0
BRK/B

Berkshire Hathaway Inc.

264,798$70.7M1.7%$222.57+19.97%
12 qtrssince 2019-Q4
Increased
47
JNJ

Johnson & Johnson

300,385$49.1M1.1%$121.78+19.74%
12 qtrssince 2019-Q4
Increased
47
COST

Costco Wholesale Corporation

92,298$43.6M1.0%$284.40+58.16%
12 qtrssince 2019-Q4
Increased
46
GOOGL

Alphabet Inc.

444,768$42.5M1.0%$74.11+27.84%
12 qtrssince 2019-Q4
Decreased
0
GOOG

Alphabet Inc.

429,228$41.3M1.0%$75.25+26.57%
12 qtrssince 2019-Q4
Decreased
0
HD

The Home Depot, Inc.

141,546$39.1M0.9%$197.67+25.83%
12 qtrssince 2019-Q4
Decreased
0
IVV
IVV
ETF

ISHARES TR

107,993$38.7M0.9%$308.09+10.21%
12 qtrssince 2019-Q4
Increased
41
JPM

JPMorgan Chase & Co.

359,758$37.6M0.9%$110.57-14.65%
12 qtrssince 2019-Q4
Decreased
0
V

Visa Inc.

181,881$32.3M0.8%$176.30-2.48%
12 qtrssince 2019-Q4
Decreased
0
QQQ
QQQ
ETF

Invesco QQQ Trust, Series 1

119,371$31.9M0.7%$232.84+12.10%
12 qtrssince 2019-Q4
Increased
43
TSLA

Tesla, Inc.

113,457$30.1M0.7%$105.39+151.69%
12 qtrssince 2019-Q4
Increased
41
PFE

Pfizer, Inc.

668,769$29.3M0.7%——
12 qtrssince 2019-Q4
Decreased
0
UNH

UnitedHealth Group Incorporated

56,014$28.3M0.7%$303.65+53.92%
12 qtrssince 2019-Q4
Increased
41
CVX

Chevron Corporation

194,169$27.9M0.7%$87.88+37.98%
12 qtrssince 2019-Q4
Decreased
0
C

Citigroup, Inc.

646,096$26.9M0.6%$53.76-32.69%
12 qtrssince 2019-Q4
Increased
43
MRK

Merck & Company, Inc.

310,229$26.7M0.6%$69.48+10.10%
12 qtrssince 2019-Q4
Decreased
0
GILD

Gilead Sciences, Inc.

417,847$25.8M0.6%$53.03+1.98%
12 qtrssince 2019-Q4
Increased
43
$4.3B
AUM
1,360
Positions
Q3 2022
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2021-Q2$5,579,469,00011.3379121915%
2021-Q3$5,342,388,000-4.24916779715%
2021-Q4$5,719,417,0007.05731219822%
2022-Q1$5,547,910,000-2.99867976054%
2022-Q2$4,645,468,000-16.2663417395%
2022-Q3$4,274,930,000-7.97633306268%
Activity profile
$ moved · Q3'22
New9%Increased24%Decreased56%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.2 years
<1Q4%1-4Q9%1-2Y14%2Y+74%

Oppenheimer & Co Inc manages $4.3B across 1360 positions as of Q3 2022. Top holdings: AAPL (4.1%), MSFT (4.0%), AMZN (1.7%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2/5.0.

Top holdings by portfolio weight

Total AUM$4B
AAPL4.13%
MSFT3.97%
AMZN1.69%
BRK/B1.65%
JNJ1.15%
COST1.02%
GOOGL1.00%
GOOG0.97%
HD0.91%
IVV0.91%
Other0.88%

Portfolio allocation by GICS sector

Sectors11
Unknown24.66%
Technology15.68%
Healthcare11.23%
Financial Services11.10%
Industrials8.18%
Consumer Cyclical7.96%
Consumer Defensive5.18%
Energy4.64%
Communication Services4.56%
Basic Materials2.32%
Other4.48%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown, Technology, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L51
Conviction46
Concentration33
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BSTZBSTZBlackRock Science and Technology Term Trust
Q4 2024 → Q3 2026+169,620 shares+$6.4M
8Q
CCHICalamos Convertible Opportunities and Income Fund
Q4 2024 → Q3 2026+128,955 shares+$1.4M
8Q
CGGRCGGRCAPITAL GROUP GROWTH ETF
Q4 2024 → Q3 2026+292,446 shares+$15.2M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used